Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Exp Dermatol. 2017 Feb 2;26(8):668–676. doi: 10.1111/exd.13261

TABLE 3.

Selected promising biomarkers for future validation studies

Diagnostic biomarkers Biomarkers of advanced disease Biomarkers of aggressive disease Biomarkers of active disease
TOX (MF)  T-plastin (SzS) Twist1 (SzS) CD158k/KIR3DL2 (SzS) LDH  CD4+CD45R0+CD45RA- SATB1 ganglioside GD3/CD60 STAT4 (loss) IL-13 TARC/CCL17 LDH  ganglioside GD3/CD60+ Fas (decrease) β2M IgE CD158k/  KIR3DL2 sialomucin (CD164) TCR clone